Cargando…

Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children

BACKGROUND: The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), accountable for Coronavirus disease 2019 (COVID-19), may cause hyperglycemia and additional systemic complexity in metabolic parameters. It is unsure even if the virus itself causes type 1 or type 2 diabetes mellitus (T1DM...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajamanickam, Anuradha, Venkataraman, Aishwarya, Kumar, Nathella Pavan, Sasidaran, R., Pandiarajan, Arul Nancy, Selvaraj, Nandhini, Mittal, Ruchi, Gowshika, K., Putlibai, Sulochana, Lakshan Raj, S., Ramanan, Padmasani Venkat, Babu, Subash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068212/
https://www.ncbi.nlm.nih.gov/pubmed/37013538
http://dx.doi.org/10.1186/s12887-023-03971-w
_version_ 1785018634042605568
author Rajamanickam, Anuradha
Venkataraman, Aishwarya
Kumar, Nathella Pavan
Sasidaran, R.
Pandiarajan, Arul Nancy
Selvaraj, Nandhini
Mittal, Ruchi
Gowshika, K.
Putlibai, Sulochana
Lakshan Raj, S.
Ramanan, Padmasani Venkat
Babu, Subash
author_facet Rajamanickam, Anuradha
Venkataraman, Aishwarya
Kumar, Nathella Pavan
Sasidaran, R.
Pandiarajan, Arul Nancy
Selvaraj, Nandhini
Mittal, Ruchi
Gowshika, K.
Putlibai, Sulochana
Lakshan Raj, S.
Ramanan, Padmasani Venkat
Babu, Subash
author_sort Rajamanickam, Anuradha
collection PubMed
description BACKGROUND: The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), accountable for Coronavirus disease 2019 (COVID-19), may cause hyperglycemia and additional systemic complexity in metabolic parameters. It is unsure even if the virus itself causes type 1 or type 2 diabetes mellitus (T1DM or T2DM). Furthermore, it is still unclear whether even recuperating COVID-19 individuals have an increased chance to develop new-onset diabetes. METHODS: We wanted to determine the impact of COVID-19 on the levels of adipokines, pancreatic hormones, incretins and cytokines in acute COVID-19, convalescent COVID-19 and control children through an observational study. We performed a multiplex immune assay analysis and compared the plasma levels of adipocytokines, pancreatic hormones, incretins and cytokines of children presenting with acute COVID-19 infection and convalescent COVID-19. RESULTS: Acute COVID-19 children had significantly elevated levels of adipsin, leptin, insulin, C-peptide, glucagon and ghrelin in comparison to convalescent COVID-19 and controls. Similarly, convalescent COVID-19 children had elevated levels of adipsin, leptin, insulin, C-peptide, glucagon, ghrelin and Glucagon-like peptide-1 (GLP-1) in comparison to control children. On the other hand, acute COVID-19 children had significantly decreased levels of adiponectin and Gastric Inhibitory Peptide (GIP) in comparison to convalescent COVID-19 and controls. Similarly, convalescent COVID-19 children had decreased levels of adiponectin and GIP in comparison to control children. Acute COVID-19 children had significantly elevated levels of cytokines, (Interferon (IFN)) IFNγ, Interleukins (IL)-2, TNFα, IL-1α, IL-1β, IFNα, IFNβ, IL-6, IL-12, IL-17A and Granulocyte-Colony Stimulating Factors (G-CSF) in comparison to convalescent COVID-19 and controls. Convalescent COVID-19 children had elevated levels of IFNγ, IL-2, TNFα, IL-1α, IL-1β, IFNα, IFNβ, IL-6, IL-12, IL-17A and G-CSF in comparison to control children. Additionally, Principal component Analysis (PCA) analysis distinguishes acute COVID-19 from convalescent COVID-19 and controls. The adipokines exhibited a significant correlation with the levels of pro-inflammatory cytokines. CONCLUSION: Children with acute COVID-19 show significant glycometabolic impairment and exaggerated cytokine responses, which is different from convalescent COVID-19 infection and controls. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-023-03971-w.
format Online
Article
Text
id pubmed-10068212
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100682122023-04-03 Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children Rajamanickam, Anuradha Venkataraman, Aishwarya Kumar, Nathella Pavan Sasidaran, R. Pandiarajan, Arul Nancy Selvaraj, Nandhini Mittal, Ruchi Gowshika, K. Putlibai, Sulochana Lakshan Raj, S. Ramanan, Padmasani Venkat Babu, Subash BMC Pediatr Research BACKGROUND: The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), accountable for Coronavirus disease 2019 (COVID-19), may cause hyperglycemia and additional systemic complexity in metabolic parameters. It is unsure even if the virus itself causes type 1 or type 2 diabetes mellitus (T1DM or T2DM). Furthermore, it is still unclear whether even recuperating COVID-19 individuals have an increased chance to develop new-onset diabetes. METHODS: We wanted to determine the impact of COVID-19 on the levels of adipokines, pancreatic hormones, incretins and cytokines in acute COVID-19, convalescent COVID-19 and control children through an observational study. We performed a multiplex immune assay analysis and compared the plasma levels of adipocytokines, pancreatic hormones, incretins and cytokines of children presenting with acute COVID-19 infection and convalescent COVID-19. RESULTS: Acute COVID-19 children had significantly elevated levels of adipsin, leptin, insulin, C-peptide, glucagon and ghrelin in comparison to convalescent COVID-19 and controls. Similarly, convalescent COVID-19 children had elevated levels of adipsin, leptin, insulin, C-peptide, glucagon, ghrelin and Glucagon-like peptide-1 (GLP-1) in comparison to control children. On the other hand, acute COVID-19 children had significantly decreased levels of adiponectin and Gastric Inhibitory Peptide (GIP) in comparison to convalescent COVID-19 and controls. Similarly, convalescent COVID-19 children had decreased levels of adiponectin and GIP in comparison to control children. Acute COVID-19 children had significantly elevated levels of cytokines, (Interferon (IFN)) IFNγ, Interleukins (IL)-2, TNFα, IL-1α, IL-1β, IFNα, IFNβ, IL-6, IL-12, IL-17A and Granulocyte-Colony Stimulating Factors (G-CSF) in comparison to convalescent COVID-19 and controls. Convalescent COVID-19 children had elevated levels of IFNγ, IL-2, TNFα, IL-1α, IL-1β, IFNα, IFNβ, IL-6, IL-12, IL-17A and G-CSF in comparison to control children. Additionally, Principal component Analysis (PCA) analysis distinguishes acute COVID-19 from convalescent COVID-19 and controls. The adipokines exhibited a significant correlation with the levels of pro-inflammatory cytokines. CONCLUSION: Children with acute COVID-19 show significant glycometabolic impairment and exaggerated cytokine responses, which is different from convalescent COVID-19 infection and controls. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-023-03971-w. BioMed Central 2023-04-03 /pmc/articles/PMC10068212/ /pubmed/37013538 http://dx.doi.org/10.1186/s12887-023-03971-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rajamanickam, Anuradha
Venkataraman, Aishwarya
Kumar, Nathella Pavan
Sasidaran, R.
Pandiarajan, Arul Nancy
Selvaraj, Nandhini
Mittal, Ruchi
Gowshika, K.
Putlibai, Sulochana
Lakshan Raj, S.
Ramanan, Padmasani Venkat
Babu, Subash
Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children
title Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children
title_full Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children
title_fullStr Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children
title_full_unstemmed Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children
title_short Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children
title_sort alterations of adipokines, pancreatic hormones and incretins in acute and convalescent covid-19 children
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068212/
https://www.ncbi.nlm.nih.gov/pubmed/37013538
http://dx.doi.org/10.1186/s12887-023-03971-w
work_keys_str_mv AT rajamanickamanuradha alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children
AT venkataramanaishwarya alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children
AT kumarnathellapavan alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children
AT sasidaranr alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children
AT pandiarajanarulnancy alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children
AT selvarajnandhini alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children
AT mittalruchi alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children
AT gowshikak alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children
AT putlibaisulochana alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children
AT lakshanrajs alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children
AT ramananpadmasanivenkat alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children
AT babusubash alterationsofadipokinespancreatichormonesandincretinsinacuteandconvalescentcovid19children